These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test. Claesson IM; Ytterberg C; Johansson S; Almkvist O; von Koch L Mult Scler; 2007 Mar; 13(2):272-4. PubMed ID: 17439898 [TBL] [Abstract][Full Text] [Related]
4. The association between cognitive impairment and quality of life in patients with early multiple sclerosis. Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429 [TBL] [Abstract][Full Text] [Related]
5. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis. Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420 [TBL] [Abstract][Full Text] [Related]
6. The cognitive burden of multiple sclerosis in children. Banwell BL; Anderson PE Neurology; 2005 Mar; 64(5):891-4. PubMed ID: 15753431 [TBL] [Abstract][Full Text] [Related]
7. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173 [TBL] [Abstract][Full Text] [Related]
8. Cognitive functioning in children and adolescents with multiple sclerosis. MacAllister WS; Belman AL; Milazzo M; Weisbrot DM; Christodoulou C; Scherl WF; Preston TE; Cianciulli C; Krupp LB Neurology; 2005 Apr; 64(8):1422-5. PubMed ID: 15851734 [TBL] [Abstract][Full Text] [Related]
9. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study. Bergendal G; Fredrikson S; Almkvist O Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938 [TBL] [Abstract][Full Text] [Related]
10. The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study. Scherer P; Penner IK; Rohr A; Boldt H; Ringel I; Wilke-Burger H; Burger-Deinerth E; Isakowitsch K; Zimmermann M; Zahrnt S; Hauser R; Hilbert K; Tiel-Wilck K; Anvari K; Behringer A; Peglau I; Friedrich H; Plenio A; Benesch G; Ehret R; Nippert I; Finke G; Schulz I; Bergtholdt B; Breitkopf S; Kaskel P; Reischies F; Kugler J Mult Scler; 2007 Apr; 13(3):402-11. PubMed ID: 17439910 [TBL] [Abstract][Full Text] [Related]
11. Cognitive impairment in multiple sclerosis. Jongen PJ; Ter Horst AT; Brands AM Minerva Med; 2012 Apr; 103(2):73-96. PubMed ID: 22513513 [TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment and decline in different MS subtypes. Huijbregts SC; Kalkers NF; de Sonneville LM; de Groot V; Polman CH J Neurol Sci; 2006 Jun; 245(1-2):187-94. PubMed ID: 16643951 [TBL] [Abstract][Full Text] [Related]
13. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Benedict RH; Duquin JA; Jurgensen S; Rudick RA; Feitcher J; Munschauer FE; Panzara MA; Weinstock-Guttman B Mult Scler; 2008 Aug; 14(7):940-6. PubMed ID: 18573822 [TBL] [Abstract][Full Text] [Related]
14. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589 [TBL] [Abstract][Full Text] [Related]
15. [Cognitive functions in multiple sclerosis]. Vicens A; Iriarte J; de Castro P; Castejón C; Martínez-Lage JM Neurologia; 1992; 7(7):171-5. PubMed ID: 1419085 [TBL] [Abstract][Full Text] [Related]
16. A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters. Denney DR; Lynch SG; Parmenter BA J Neurol Sci; 2008 Apr; 267(1-2):129-36. PubMed ID: 17976653 [TBL] [Abstract][Full Text] [Related]
17. Benign or not benign MS: a role for routine neuropsychological assessment? Benedict RH; Fazekas F Neurology; 2009 Aug; 73(7):494-5. PubMed ID: 19641172 [No Abstract] [Full Text] [Related]
18. Assessment and rehabilitation of cognitive impairment in multiple sclerosis. Messinis L; Kosmidis MH; Lyros E; Papathanasopoulos P Int Rev Psychiatry; 2010; 22(1):22-34. PubMed ID: 20233112 [TBL] [Abstract][Full Text] [Related]
19. [Cognitive dysfunction as a hidden multiple sclerosis related symptom relevant for an expert appraisal]. Kraus J; Lohmann H; Evers S Fortschr Neurol Psychiatr; 2009 Jan; 77(1):38-43. PubMed ID: 19101878 [TBL] [Abstract][Full Text] [Related]
20. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. Benedict RH; Carone DA; Bakshi R J Neuroimaging; 2004 Jul; 14(3 Suppl):36S-45S. PubMed ID: 15228758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]